Related Experiment Video
Updated: Jul 14, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
ERBB receptors in developing, dysplastic and malignant oral epithelia
J Rautava1, K J Jee, P J Miettinen
1Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, Fin-20520, Turku, Finland. jaapoh@utu.fi <jaapoh@utu.fi>
Abstract:
Some oral squamous cell carcinomas (OSCCs) overexpress epidermal growth factor receptor (EGFR) but little is known about the receptor system overall during oral carcinogenesis. We studied all four ERBB receptors (EGFR, ERBB2-4) in developing (n=2), normal (n=7), dysplastic (n=23) and malignant (n=26) oral epithelia by means of immunohistochemistry. The investigations were supplemented by conducting reverse transcription-polymerase chain reactions in relation to 13 OSCC samples. All four ERBB receptors were detected in developing oral epithelium and, to a lesser degree, in mature oral epithelium. An increase in EGFR immunoreactivity was seen in 61% and 54% of dysplasias and OSCCs, respectively. The corresponding percentages for ERBB2 were 48 and 12, for ERBB3 48 and 43. ERBB4 nuclear staining was increased in 30% of dysplasias and 26% of OSCCs. Changes in ERBB receptor mRNA levels were not statistically significant. The results show that ERBB receptor profiles are specific to each tumour. Increased nuclear translocation of ERBB4 in some OSCCs may alter transcription of target genes and be associated with cancer progression. This information may be useful for clinicians as EGFR inhibitors are becoming treatment options in modern oncology.
Insights
This study investigated all four ERBB receptors in oral carcinogenesis. Increased epidermal growth factor receptor (EGFR) and ERBB4 nuclear staining were observed in oral dysplasias and squamous cell carcinomas (OSCCs).
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Oral squamous cell carcinomas (OSCCs) often overexpress epidermal growth factor receptor (EGFR).
- The role of the entire ERBB receptor system in oral carcinogenesis is not fully understood.
- ERBB receptors (EGFR, ERBB2, ERBB3, ERBB4) are crucial in cell growth and differentiation.
Purpose of the Study:
- To investigate the expression and localization of all four ERBB receptors (EGFR, ERBB2-4) in normal, dysplastic, and malignant oral epithelia.
- To correlate ERBB receptor expression with oral carcinogenesis.
- To explore the potential clinical implications of ERBB receptor alterations in OSCC.
Main Methods:
- Immunohistochemistry was used to study ERBB receptor expression in developing, normal, dysplastic, and OSCC tissues (n=58).
- Reverse transcription-polymerase chain reaction (RT-PCR) was performed on 13 OSCC samples to assess ERBB receptor mRNA levels.
- Quantitative analysis of receptor immunoreactivity and localization (cytoplasmic vs. nuclear) was conducted.
Main Results:
- All four ERBB receptors were detected in developing and mature oral epithelium.
- Increased epidermal growth factor receptor (EGFR) immunoreactivity was found in 61% of dysplasias and 54% of OSCCs.
- Elevated ERBB4 nuclear staining was observed in 30% of dysplasias and 26% of OSCCs, suggesting potential roles in cancer progression.
Conclusions:
- ERBB receptor expression profiles are distinct in different stages of oral carcinogenesis.
- Increased nuclear translocation of ERBB4 may influence gene transcription and contribute to OSCC progression.
- Understanding ERBB receptor dynamics offers potential therapeutic targets, especially with emerging EGFR inhibitors in oncology.
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cellular Adaptation IV: Dysplasia and Metaplasia

